GSC
COCP icon

Ground Swell Capital’s Cocrystal Pharma COCP Stock Holding History

Ground Swell Capital’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Buy
+10,752
New +$13.2K 0.01% 113

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ground Swell Capital's COCP Position: Q2 2026 in Review

Ground Swell Capital opened a new position in Cocrystal Pharma (COCP) in Q2 2026: 10,752 shares worth $11.3K. The stake represents 0.01% of the portfolio and ranks #113 among its holdings.

19 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Ground Swell Capital held 10,752 shares of Cocrystal Pharma worth $11.3K as of Q2 2026.
  • Cocrystal Pharma was a new Ground Swell Capital position in Q2 2026.
  • Cocrystal Pharma made up 0.01% of Ground Swell Capital's portfolio in Q2 2026, its #113 holding.
  • 19 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Ground Swell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.